![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 17, 15085-15092, April 26, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
¶
From the Departments of
Neuroscience and
§ Pharmaceutics, University of Minnesota,
Minneapolis, Minnesota 55455
Received for publication, December 10, 2001, and in revised form, February 1, 2002
| |
ABSTRACT |
|---|
|
|
|---|
We have recently demonstrated that anionic
liposomes efficiently introduce foreign DNA into postmitotic
neurons and other cell types (Lakkaraju, A., Dubinsky, J. M.,
Low, W. C., and Rahman, Y.-E. (2001) J. Biol. Chem.
276, 32000-32007). To investigate the mechanism of liposome
uptake, we followed the internalization of anionic
liposome-encapsulated Cy3-labeled oligonucleotides (AL-Cy3ONs) by
hippocampal neurons using confocal microscopy. Uptake of AL-Cy3ONs was
widespread and time- and temperature-dependent, indicative
of receptor-mediated endocytosis. The low-density lipoprotein receptor-related protein (LRP) was crucial for anionic
liposome endocytosis because the receptor-associated protein or an
anti-LRP antibody inhibited internalization, and fibroblasts lacking
LRP did not internalize AL-Cy3ONs. Using selective endocytosis
inhibitors, we found that liposome endocytosis and intracellular
transport required clathrin, dynamin, an intact cytoskeletal network,
and phosphatidylinositol 3-kinase activity. Cy3ONs did not
significantly colocalize with recycling endosomal/lysosomal markers and
entered neuronal nuclei within 1-3 h of incubation. Approximately 50% of the internalized liposomal phospholipids were recycled back to the
cell surface, in keeping with the fluidity of their acyl chains.
Liposome endocytosis did not require heparan sulfate proteoglycans or
cause calcium influx into neurons. Thus, constitutive endocytosis of
anionic liposomes by LRP utilizes only one component, in contrast to
the more involved heparan sulfate proteoglycan-LRP pathway implicated
in the pathogenesis of Alzheimer's disease.
Endocytosis in neurons has mainly been studied in the context of
synaptic vesicle recycling (1) and the regulation of neurotransmitter receptor numbers in the post-synaptic membrane (2). Constitutive endocytosis also occurs in neurons, albeit at a slower rate than in
non-polarized or mitotically active cells. Growth factors and hormones
modulate the rate of constitutive endocytosis of neurotransmitter receptors as well as receptors involved in nutrient acquisition and
metabolism. Neurotrophins such as nerve growth factor and bone-derived
neurotrophic factor increase both the recruitment of clathrin to the
plasma membrane and the rate of constitutive endocytosis of
transferrin in hippocampal neurons (3).
Little is known, however, about the mechanisms of internalization of
exogenous macromolecules such as phospholipids and nucleic acids in
neurons. Insight into the interactions between neurons and these
molecules would further our understanding of lipid and DNA transport
pathways and provide potential therapeutic advantages. We have recently
designed and developed an anionic liposome vector (composed of the
anionic phospholipid dioleoylphosphatidylglycerol and the zwitterionic
phospholipid dioleoylphosphatidylcholine) for oligonucleotide delivery
to neurons. Antisense oligonucleotides targeted to the p53 tumor
suppressor mRNA, delivered to neurons via anionic liposomes,
efficiently protected hippocampal neurons from excitotoxic death by
sequence-specific down-regulation of p53 protein expression (4).
Preliminary studies indicated that the uptake of Cy3-labeled
oligonucleotides (Cy3ONs)1
encapsulated in anionic liposomes was rapid and widespread.
This study was undertaken to delineate the mechanism of liposome
internalization in neurons. Cy3ONs were encapsulated in anionic liposomes, and the uptake of these molecules by cultured rat
hippocampal neurons was studied by confocal microscopy. Each stage in
the endocytic pathway was retarded by biochemically interfering with specific proteins to determine the role of that protein in the internalization of liposomes. Here we demonstrate that anionic liposomes utilize constitutive endocytosis of the low-density lipoprotein receptor-related protein (LRP) to enter neurons, followed by intracellular transport and processing via a classical endocytic pathway. In addition to providing a mechanistic basis for
oligonucleotide delivery by anionic liposomes, our results have also
identified an efficient phospholipid transport pathway in neurons. This
pathway appears to be a previously unrecognized, independent component of the more involved LRP-mediated endocytic pathway that has been implicated in the processing of the amyloid precursor protein and the
pathogenesis of Alzheimer's disease.
Oligonucleotides and Liposomes--
An antisense oligonucleotide
to the p53 mRNA was designed as previously described (4).
Oligonucleotides were synthesized and labeled at the 5'-end with Cy3
and purified by reverse-phase high performance liquid
chromatography to remove free dye (Integrated DNA Technologies). The
oligonucleotides were reconstituted in sterile, nuclease-free Tris/EDTA
buffer (pH 7.2) and stored at Cell Culture and Treatments--
Primary cultures of hippocampal
neurons were prepared from neonatal rat pups (postnatal day 1 or
2) as previously described (4, 5) and cultured on 22-mm square
glass coverslips or eight-chambered glass slides (LabTek II, Nalgene
Nunc) in serum-free Neurobasal medium with vitamin B27
supplements unless otherwise stated. Neurons were incubated with 2 µM Cy3ONs (free, encapsulated in anionic liposomes, or
complexed with cationic liposomes) for 30 min at 37 °C unless stated
otherwise. For low-temperature studies, neurons were incubated at
4 °C with AL-Cy3ONs for 10 min. The LRP-deficient mouse embryonic
fibroblast cell line PEA-13 and its wild-type counterpart MEF-1 (6)
were obtained from American Type Culture Collection. These cells were
cultured on eight-chambered glass slides in Dulbecco's modified
Eagle's medium containing penicillin and streptomycin with 10% Cosmic
calf serum (Hyclone Laboratories) and incubated with AL-Cy3ONs for
either 1 or 3 h at 37 °C. At the end of the incubation periods,
uninternalized oligonucleotides, liposomes, or complexes were removed
by several washes with Leibovitz L-15 medium and fixed in 4% paraformaldehyde.
The following agents were used to manipulate specific steps of the
endocytic cycle: 0.45 M hyperosmolar sucrose (ICN
Biochemicals); 1 µM FK506 (Calbiochem); and 100 nM wortmannin, 5 µg/ml nocodazole, 10 µg/ml
cytochalasin D, 100 µg/ml heparin, and 100 µg/ml protamine sulfate
(all from Sigma). The LRP inhibitor receptor-associated protein (RAP)
and the LRP-blocking antibody R2629 were used at concentrations of 500 nM (7) and 100 µg/ml (6), respectively. Cells were
treated with the drugs, RAP, or R2629 for 10 min prior to incubation
with AL-Cy3ONs for 30 min at 37 °C, fixed, and imaged.
Colocalization Experiments--
Intracellular fates of
endocytosed liposomes and oligonucleotides were determined by comparing
their intracellular distributions with those of Oregon Green
488-transferrin (OG-Tf) and Alexa 488-dextran (Molecular Probes, Inc.),
used as markers for the recycling and lysosomal compartments,
respectively. Neurons were incubated with AL-Cy3ONs and either 100 µg/ml OG-Tf for 0.5, 1, or 3 h or 1 mg/ml Alexa 488-dextran for
3 h. For phospholipid transport experiments, neurons were
incubated with liposomes labeled with N-Rh-DOPE and either OG-Tf for
0.5, 1, or 3 h or 1 mg/ml Alexa-dextran for 3 h. These time
points were chosen based on earlier work on the kinetics of transferrin
and dextran endocytosis in hippocampal neurons (3, 8, 9). At the end of
the incubation periods, cells were rinsed and fixed for imaging as
described above.
Confocal Microscopy and Image Analysis--
Imaging was
performed on a Leica TCS 4D confocal microscope equipped with a
mercury/xenon lamp and an argon/krypton laser. Cells were excited using
the 488 nm laser line to detect OG-Tf and Alexa 488-dextran, and the
emitted fluorescence was collected using a 515 nm long-pass
filter. The 568 nm laser line was used to excite Cy3 and N-Rh-DOPE
(LP590 emission). Cells were imaged at a plane midway between
the substrate-attached plasma membrane and the top of the cell, such
that neuronal nuclei were clearly identifiable. In some cases, the
entire volume of the cell was scanned in 0.5-µm increments. For
experiments with Alexa 488-dextran, planes in which the Alexa 488 label
was most visible were chosen to enable identification of late
endosomal/lysosomal structures. Optimal images were obtained by
averaging 16 images in the line-scan mode at the same fixed gains for
all experiments. For the colocalization experiments, the cell outlines
for each set of fields were traced out manually in the corresponding
bright-field image and then used to mask the fluorescence images
(Metamorph, Universal Imaging Corp.). In each cell, the total
fluorescence intensity was measured, and the percent of Cy3 or
rhodamine label that colocalized with the Oregon Green 488 or Alexa 488 label was calculated. All the representative fluorescence images shown
in the figures were equally contrast-enhanced using Adobe
Photoshop®.
Calcium Imaging--
Hippocampal neurons cultured on 35-mm
glass-bottomed Petri dishes (5) were loaded with 4 µM
fura-2/AM (Molecular Probes, Inc.) for 30 min. The cultures were
mounted in recording solution containing 139 mM NaCl, 3 mM KCl, 10 mM NaHEPES, 1.8 mM
CaCl2, 0.8 mM MgCl2, 5 mM glucose, 15 mM sucrose, and 0.1 mM glycine (pH 7.4) on the stage of an inverted Nikon
Diaphot microscope. The recording solution also contained 1 µM tetrodotoxin to inhibit spontaneous firing of the
neurons. Images were captured with a ×40 objective every 20 s
(Metafluor, Universal Imaging Corp.) using the following wavelengths:
fura-2, excitation at 340 ± 15 and 380 ± 15 nm attenuated
with a 10% quartz neutral density filter and emission at 525 ± 25 nm; and N-Rh-DOPE, excitation at 565 ± 15 nm and emission at
>590 nm (10). All images were corrected by subtracting a
wavelength-specific background from an unpopulated portion of the dish.
In preliminary experiments, the addition of recording solution
or liposomes by manual pipetting caused a transient increase in
intracellular Ca2+. To avoid this artifact, anionic
liposomes labeled with N-Rh-DOPE were perfused onto the neurons at a
rate of 1 ml/min for 10-15 min.
Protein Binding to Liposomes--
Neurons were incubated with
100 µl of liposomes in recording solution (as described above) for
3 h with or without 500 nM RAP. The medium overlying
the cells was first centrifuged at 320 × g for 8 min
to remove cell debris, followed by centrifugation at 100,000 × g for 15 min at 25 °C in a Beckman ultracentrifuge to
recover the liposomes (11). The liposome pellet was resuspended in 10 mM HEPES (pH 7.4) containing 150 mM NaCl, and
an aliquot was analyzed using the highly sensitive
3-(4-carboxybenzoyl)quinoline-2-carboxaldehyde (CBQCA) protein
assay kit (Molecular Probes, Inc.) to determine whether any proteins
secreted into the medium bound to liposomes. Fluorescence associated
with any protein bound to the liposomes labeled by the CBQCA reagent
was detected using a PerkinElmer Life Sciences LS55 fluorometer.
Neuronal Uptake of Anionic Liposomes Occurs by Clathrin-mediated
Endocytosis--
Incubation of hippocampal neurons with anionic
liposomes containing 2 µM Cy3ONs for 30 min at 37 °C
resulted in the localization of the labeled oligonucleotides in
vesicular cytoplasmic structures, but not in the nucleus (Fig.
1a). After a 1-h incubation,
diffuse Cy3 fluorescence was observed in the nucleus (Fig.
1b). The intensity of the diffuse nuclear label increased
after 3 h, and portions of the cytoplasm often contained uniform
Cy3 fluorescence, in addition to the punctate label (Fig.
1c). Virtually all the neurons examined under the microscope
and/or imaged exhibited Cy3 fluorescence 30 min after incubation with
anionic liposomes. Uptake of anionic liposomes was greatly reduced at
4 °C, with Cy3 fluorescence seen only at the cell surface,
indicating binding of liposomes to the plasma membrane, but not
internalization (Fig. 1d). The time- and
temperature-dependent uptake of anionic liposomes
containing Cy3ONs suggested that liposome internalization into neurons
occurred by endocytosis and was possibly receptor-mediated. To identify the cellular elements required for liposome uptake, we inhibited various steps in the endocytic pathway. Fig.
2 depicts the incidence of intracellular
Cy3 fluorescence in neurons following various experimental
manipulations.
Cell-surface receptors concentrated in clathrin-coated pits mediate the
endocytosis of many macromolecules. To determine whether clathrin-coated pits are involved in the uptake of anionic liposomes, hyperosmolar sucrose was used to disrupt clathrin assemblies (12). Treatment of neurons with 0.45 M sucrose completely
prevented internalization of anionic liposomes containing Cy3ONs (Fig.
3b) compared with cells
treated with AL-Cy3ONs alone (Fig. 3a). This confirmed that
neuronal uptake of liposomes was receptor-mediated because
hyperosmolarity inhibits receptor-mediated endocytosis, but does not
interfere with nonspecific fluid-phase endocytosis (13).
Clathrin-dependent endocytosis involving accessory proteins
such as the GTPase dynamin, amphiphysin, and synaptojanin plays a
critical role in synaptic vesicle recycling at nerve terminals (14).
Dynamin and amphiphysin need to be dephosphorylated by the
Ca2+/calmodulin-dependent phosphatase
(calcineurin) to interact with one another and the lipid bilayer (15).
We used a calcineurin inhibitor (FK506) to study the role of dynamin in
anionic liposome internalization. Treatment of neurons with FK506 prior
to the addition of AL-Cy3ONs significantly decreased liposome
endocytosis (Fig. 3c), providing further evidence that
liposomes are internalized in neurons via clathrin-coated pits.
Liposome Endocytosis Occurs via LRP--
LRP, a member of the
low-density lipoprotein receptor gene family, is highly expressed in
the mammalian central nervous system and has been implicated in the
endocytosis of several unrelated ligands (7). A major function of
lipoprotein receptors is the regulation of lipoprotein uptake and
metabolism (16). Immunofluorescence staining with an antibody to LRP
confirmed that this receptor was highly expressed in our hippocampal
neuronal cultures (see Supplemental Material). To determine whether LRP
is involved in the endocytosis of anionic liposomes, we blocked LRP
using RAP, which is a potent inhibitor of all known ligand interactions
of LRP (7). RAP binds with high affinity to the heavy chain of LRP on
multiple ligand-binding domains and induces a conformational change in
the receptor, thus interfering with ligand binding (17). When neurons
were incubated with AL-Cy3ONs in the presence of RAP, both binding and
internalization of anionic liposomes were inhibited. Note the complete
absence of Cy3 fluorescence both on the cell surface and within
the RAP-treated neurons (Fig.
4b) compared with treatment
with AL-Cy3ONs alone (Fig. 4a). Further evidence for the
involvement of LRP in anionic liposome endocytosis was obtained when
preincubation of neurons with the neutralizing LRP antibody R2629 (6)
also prevented AL-Cy3ON uptake (Fig. 4c).
Last, we compared the endocytosis of AL-Cy3ONs in immortalized mouse
embryonic fibroblast cell lines that either expressed LRP (MEF-1) or
lacked the receptor (PEA-13). After a 1-h incubation, almost all MEF-1
cells displayed robust Cy3 fluorescence (Fig. 5a), in contrast to the faint
signal seen in PEA-13 cells (Fig. 5b). Following a 3-h
incubation, Cy3 fluorescence was visible in the PEA-13 cultures at
lower intensity than in the MEF-1 cells, indicating that liposomes were
being taken up by the PEA-13 cells, albeit with very slow kinetics. In
contrast to the MEF-1 cultures, where all the cells examined had the
Cy3 label, only 50-60% of the PEA-13 cells exhibited Cy3 fluorescence
after 3 h (Fig. 5, compare c and d).
Endocytosis of AL-Cy3ONs via LRP Is Independent of HSPGs and Does
Not Alter Neuronal Calcium Influx--
Several LRP ligands, including
To determine whether endogenous proteins secreted by neurons can bind
liposomes and act as intermediaries between liposomes and LRP, we
measured protein binding to liposomes after a 3-h incubation with
neurons. Incubations were carried out in either the absence or presence
of 500 nM RAP to increase the possibility of protein-bound
liposomes being recovered from the medium. The amount of protein
detected by the CBQCA assay did not significantly differ between the
untreated and RAP-treated controls and liposome-treated conditions (one-way analysis of variance, p = 0.5) (Table I). As a positive control,
liposomes were incubated with poly-L-lysine (lysine/lipid
phosphate charge ratios of 0.6 and 2), and 100% of the added
polylysine was detected in the liposome pellet (data not shown). As the
amine moiety on the choline head group of dioleoylphosphatidylcholine was found to interact with the CBQCA dye, standard curves with bovine
serum albumin were constructed in solutions containing liposomes, and
the samples were diluted to minimize lipid interference. We were able
to detect 10 ng of exogenously added bovine serum albumin (data not
shown), indicating that within the limits of sensitivity of this assay,
no endogenous proteins from cultured neurons bound liposomes.
Recent studies on cortical neurons and hippocampal slices have
suggested a role for LRP in synaptic neurotransmission (20, 21). The
addition of activated Intracellular Trafficking of Anionic Liposomes Is Associated with
the Cytoskeleton and Requires PI 3-Kinase
Activity--
Microtubule-dependent movement is a
predominant means of axonal and dendritic transport in neurons (22). To
determine whether intracellular trafficking of AL-Cy3ONs requires an
intact microtubule network, we used nocodazole to depolymerize
microtubules in hippocampal neurons. When neurons were incubated with
anionic liposomes in the presence of nocodazole, the Cy3 label was
found only at the edges of the cell and on the plasma membrane (Fig.
7b).
Although an actin-based framework is required for the organization of
clathrin-coated pits at the cell surface, the role of actin in
receptor-mediated endocytosis is still unclear (23, 24). The
involvement of the actin cytoskeleton in liposome endocytosis was
studied using cytochalasin D to depolymerize actin filaments. In
contrast to nocodazole-treated neurons, no Cy3 fluorescence was
detected in neurons incubated with AL-Cy3ONs in the presence of
cytochalasin D (Fig. 7c). This confirms previous reports
that the cytochalasin D-sensitive step precedes the
nocodazole-sensitive step in receptor-mediated endocytosis (25).
Activation of the PI 3-kinase family of lipid kinases is involved in
the rearrangement of cytoskeletal proteins, vesicle sorting, and
receptor recycling during endocytosis. Specific inhibitors such as
wortmannin have been widely used to study the potential sites of PI
3-kinase function in the endocytic pathway (26). To determine whether
PI 3-kinase activity is necessary for neuronal endocytosis of anionic
liposomes, neurons were incubated with wortmannin prior to the addition
of AL-Cy3ONs. A low level of cell-associated Cy3 fluorescence was
observed in neurons pretreated with wortmannin for 10 min (Fig.
7d), and increasing wortmannin exposure time beyond 10 min
not only abolished the internalization of liposomes, but also caused
formation of vacuoles associated with the plasma membrane (data not
shown). Other studies have also documented a temporal correlation
between exposure to wortmannin and drastic changes in organelle
morphology (27).
Cytoplasmic Cy3ONs Do Not Significantly Colocalize with
Organelles Containing Transferrin or Dextran--
To determine the
identity of vesicular structures containing the Cy3 label, we incubated
neurons with AL-Cy3ONs along with either Oregon Green 488-transferrin
as a marker for the recycling endosomal pathway or Alexa 488-dextran as
a fluid-phase marker for the lysosomal degradative pathway for
different time periods (Fig. 8,
a and b; and Table
II). After 30 min of co-incubation, 15%
of the total intracellular Cy3 label was present in the same organelles
as transferrin. The proportion of total Cy3 that colocalized with
transferrin did not increase beyond 25% even after 3 h of incubation. Only 20% of the total cell-associated Cy3 was present in
compartments containing dextran. The lack of significant colocalization between Cy3ONs and transferrin suggested that either Cy3ONs do not
undergo recycling or that recycling does occur, but with kinetics that
are far slower than that of transferrin. As only 20% of Cy3ONs were
present in lysosomal compartments after 3 h, the bulk of the cargo
delivered by the endocytosed anionic liposomes was available to the
cell.
Liposomal Lipids Are Preferentially Sorted into Recycling
Compartments--
Recent evidence suggests that lipids endocytosed
from the plasma membrane are sorted into either recycling endosomes or
late endosomes based on the length and degree of unsaturation in their acyl chains (28). To determine whether the dioleoylphospholipids (two
18-carbon acyl chains with one cis-double bond each)
dioleoylphosphatidylcholine and dioleoylphosphatidylglycerol used in
our studies were sorted according to this model, we used the head
group-labeled lipid N-Rh-DOPE to tag the liposomes. As head
group-labeled lipids do not spontaneously transfer between membrane
leaflets, they can be expected to label liposomal lipids reliably
during membrane trafficking after internalization (29). Fluorescence
resonance energy transfer measurements between unlabeled and
N-Rh-DOPE-labeled liposomes demonstrated that self-quenching of
rhodamine within the bilayer was relieved only by calcium-induced
liposome aggregation and fusion and not by simple mixing of labeled and
unlabeled liposomes (data not shown). Neurons were incubated with
N-Rh-DOPE-labeled liposomes and the recycling endosomal or lysosomal
markers for various time periods (Fig. 8, c and
d). Approximately 50% of the internalized liposomal lipid
colocalized with transferrin, suggesting that the fluid nature of the
phospholipids used in this study led to their preferential sorting into
recycling compartments (Table II).
Trafficking of Anionic Liposomes in Hippocampal Neurons--
A
classical endocytic pathway involving LRP was responsible for the
uptake and intracellular transport of anionic liposomes (see
Supplemental Material for a schematic of the liposome uptake pathway).
Three lines of evidence indicate that LRP is crucial for liposome
endocytosis (Figs. 4 and 5): pretreatment of neurons with (i) RAP or
(ii) a neutralizing LRP antibody inhibited binding and subsequent
internalization of liposomes, and (iii) uptake of AL-Cy3ONs in
fibroblasts lacking LRP was markedly reduced compared with those
expressing the receptor. Although RAP is known to block ligand binding
to all members of the low-density lipoprotein receptor family, the
neutralizing antibody is specific for LRP. Furthermore, previous
studies have demonstrated no difference between the LRP-expressing and
LRP-deficient fibroblasts in low-density lipoprotein receptor function
(6), indicating that LRP, and not another member of the low-density
lipoprotein receptor family, is responsible for anionic liposome uptake.
Internalization of the receptor-liposome complex was inhibited at low
temperatures (Fig. 1) because interaction of the receptor's cytoplasmic internalization signal with the clathrin adaptor protein AP2 is temperature-sensitive (30). Random dispersal of receptors on the
membrane by treatment with hyperosmolar sucrose (12) or interference
with scission of the coated pit by treatment with FK506 (15) both
inhibited anionic liposome endocytosis (Fig. 3). An intact cytoskeleton
and PI 3-kinase activity were also required for anionic liposome
endocytosis (Fig. 7). Treatment with wortmannin greatly reduced Cy3
fluorescence in neurons, in agreement with reports that recruitment of
LRP to the cell surface from endosomal storage pools is almost
completely inhibited by wortmannin (31).
Colocalization experiments with endosomal/lysosomal markers
indicated that Cy3ONs were neither recycled nor rapidly degraded within
neurons (Fig. 8, a and b). Alternatively,
oligonucleotide recycling may occur with slower kinetics compared with
transferrin, like glycosylphosphatidylinositol-anchored proteins that
are recycled approximately three times more slowly than transferrin
(32). The length and fluidity of the acyl chains determined the
intracellular fate of liposomal phospholipids (Fig. 8, c and
d). The dioleoyllipids used in our study preferentially
partitioned into fluid membrane domains with concave curvature and were
sorted into transferrin-containing tubulovesicular recycling endosomes.
The differential colocalization of oligonucleotides and liposomal
lipids with transferrin indicated divergence in their intracellular
paths 30-60 min after endocytosis. After receptor-ligand dissociation,
proteins of the annexin family on the luminal surface of endosomes may
bind to the anionic liposomes. Annexins cause lateral segregation of
phosphatidylglycerol in mixed bilayers of phosphatidylcholine and
phosphatidylglycerol in the presence of physiological concentrations of
Ca2+ (33). Liposome destabilization by annexins would then
provide a conduit for oligonucleotides into the cytoplasm, from where they can freely diffuse into the nucleus, accounting for the
differential sorting of the lipids and oligonucleotides.
LRP-mediated Endocytosis for Macromolecule Delivery to
Neurons--
In marked contrast to the rapid and widespread uptake of
Cy3ONs delivered by anionic liposomes, neurons incubated with Cy3ONs either free or complexed with the cationic lipid dimethylaminoethane carbamoylcholesterol/dioleoylphosphatidylethanolamine exhibited minimal
intracellular Cy3 fluorescence (Fig. 2 and Supplemental Material). LRP
is a receptor that is concentrated in coated pits in the absence of any
stimulus (34) and is constitutively endocytosed, irrespective of ligand
binding. In Chinese hamster ovary cells, ~60% of cell-surface LRP is
endocytosed within 5 min, and ~50% of the internalized LRP is
recycled within 30-60 min (35). The high sequence variability between
the 31 ligand-binding sites of LRP endows different domains with unique
charge densities and hydrophobic patches, resulting in distinct ligand
recognition sites (36, 37). Initial binding of many LRP ligands with
basic residues occurs via HSPGs, which concentrate ligand on the cell surface and present it to LRP for internalization (38). In contrast, endocytosis of anionic liposomes was independent of HSPGs (Fig. 6a), indicating that liposomes may interact directly with
LRP. The observation of uptake during liposome perfusion in
protein-free solution and the analysis of liposomes harvested after
incubation with neurons (Fig. 6 and Table I) suggest that proteins
either present in or secreted into the medium do not bind or mediate liposome endocytosis via LRP. The spatially restricted calcium influx
reported in primary neurons following multivalent ligand binding to LRP
(20) was not observed in our experiments (Fig. 6, b and
c), suggesting that liposomes do not induce LRP
multimerization and that liposome endocytosis by LRP is distinct from
that of other LRP ligands.
The widespread expression of LRP (39) should enable anionic liposomes
to deliver nucleic acids and possibly proteins to a broad spectrum of
cell types (4) and tissues. In light of recent evidence that stressful
external stimuli increase the rate of endocytosis (40), the
LRP-dependent pathway of anionic liposome uptake into
neurons holds important implications for therapeutic approaches in a
number of diseases.
Physiological Relevance of LRP-mediated Phospholipid Uptake in
Neurons--
It is well established that the synthesis and metabolism
of cholesterol and phospholipids in the central nervous system are compartmentalized from those in the plasma by the blood brain barrier
(41). Astrocytes package cholesterol into apoE-containing lipoprotein
particles that are then taken up by neurons through LRP-mediated
endocytosis (42). Recent studies demonstrate that apoE lipoproteins,
internalized via LRP, promote neurite outgrowth (43) and synaptogenesis
(44). Furthermore, Alzheimer's disease is associated with altered
phospholipid metabolism and marked reductions in the
phosphatidylcholine content of synaptosomes and plasma membranes of
Alzheimer's disease hippocampi (45). Levels of apoE and
phosphatidylcholine precursors increase in parallel with neurite
sprouting in the lesioned hippocampus, probably enabling membrane
synthesis and dendritic rearrangement (46). The importance of
LRP-mediated endocytosis in the growth and maintenance of neuronal
structural plasticity is underscored by the rapid mobilization of LRP
to the plasma membrane from intracellular storage pools following
treatment with nerve growth factor (47). Growth factor-induced increase
in the endocytosis of lipoproteins may be a way of providing neurons
with the lipids and proteins necessary for growth and regeneration.
LRP-ligand interactions and apoE-delivered cholesterol have been
implicated in numerous intracellular signal transduction events (48).
In addition, multivalent ligand binding to LRP causes local influx of
Ca2+ (20) and affects synaptic neurotransmission (21),
probably by triggering N-methyl D-aspartate
receptor clustering because the cytoplasmic tail of LRP physically
interacts with N-methyl D-aspartate receptors
via PSD95 (49). Modulation of downstream signaling cascades and
neurotransmission by the apoE-HSPG-LRP pathway have been hypothesized
to play a role in Alzheimer's disease pathogenesis (48). However, our
results demonstrate for the first time that constitutive endocytosis of
liposomes by LRP utilizes only one component of the LRP endocytic
pathway, without involving HSPGs or altering intracellular calcium
levels. The existence of an endogenous phospholipid ligand in the
central nervous system that might activate LRP-mediated endocytosis
independent of HSPGs remains to be determined.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
20 °C. Encapsulation of
oligonucleotides in anionic liposomes (87.5 mol % dioleoylphosphatidylcholine and 12.5 mol % dioleoylphosphatidylglycerol), their characterization, and complexation
of oligonucleotides with cationic liposomes were all performed as
previously detailed (4). Liposomes labeled with N-Rh-DOPE were prepared
in a manner identical to that described for liposomes encapsulating
Cy3ONs, except that the lipid films contained 1-2.5 mol % N-Rh-DOPE,
and the liposomes were prepared with buffer alone (i.e.
without oligonucleotides).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (66K):
[in a new window]
Fig. 1.
An energy-dependent process is
responsible for the internalization of AL-Cy3ONs.
Intracellular Cy3 fluorescence was observed at 0.5 (a), 1 (b), and 3 (c) h after
incubation at 37 °C. Note the strong Cy3 fluorescence in neuronal
nuclei in b and c. Internalization, but not
binding of AL-Cy3ONs to the plasma membrane, was inhibited at 4 °C
(d). Brightfield images in the lower panels
correspond to the indicated fluorescent fields. Scale
bars = 5 µm.

View larger version (18K):
[in a new window]
Fig. 2.
Comparison of uptake of Cy3-labeled
oligonucleotides encapsulated in anionic liposome across all
experiments. Bars represent percent of imaged neurons
(n = 45-120) containing punctate Cy3 fluorescence 30 min after the indicated incubation at 37 °C unless otherwise stated.
Final Cy3ON concentration was 2 µM in all experiments.
4°C, incubation performed at 4 °C;
Suc, 0.45 M sucrose; FK, 1 µM FK506; RAP, 500 nM RAP;
Hep, 100 µg/ml heparin; Prot, 100 µg/ml
protamine sulfate; Noc, 5 µg/ml nocodazole;
Wort, 100 nM wortmannin; Cy3ON,
neurons incubated with Cy3ONs alone, without liposomes;
pCL-Cy3ON, Cy3ONs complexed with cationic liposomes at a net
positive charge; nCL-Cy3ON, Cy3ONs complexed with cationic
liposomes at a net negative charge.

View larger version (74K):
[in a new window]
Fig. 3.
Internalization of AL-Cy3ONs proceeds by a
clathrin-mediated, dynamin-dependent pathway.
Pretreatment of neurons with 0.45 M sucrose (b)
or 1 µM FK506 (c) decreased the
internalization of AL-Cy3ONs compared with cells treated with AL-Cy3ONs
alone (a). Scale bar = 5 µm.

View larger version (93K):
[in a new window]
Fig. 4.
Endocytosis of anionic liposomes is mediated
by LRP. Pretreatment with 500 nM RAP (b) or
100 µg/ml anti-LRP antibody (c) inhibited both binding and
endocytosis of AL-Cy3ONs compared with cells treated with AL-Cy3ONs
alone (a). Scale bars = 5 µm.

View larger version (74K):
[in a new window]
Fig. 5.
Cell-surface expression of LRP is essential
for the rapid uptake of AL-Cy3ONs. After a 1-h incubation with
AL-Cy3ONs, the Cy3 label was visible in LRP-expressing MEF-1 cells
(a), but not in LRP-deficient PEA-13 cells (b).
Following a 3-h incubation, some Cy3 label was visible in PEA-13 cells
(d), although far less than that seen in MEF-1 cells
(c). Scale bars = 10 µm.
2-macroglobulin, apoE, and HIV Tat protein, bind HSPGs
on the cell surface prior to being internalized by LRP. Consequently,
RAP does not inhibit binding of HIV Tat to the plasma membrane, but
inhibits its internalization and subsequent degradation (18). To
determine whether HSPGs are necessary for liposome endocytosis by LRP,
we incubated neurons with AL-Cy3ONs along with 100 µg/ml heparin or
protamine sulfate. Heparin is a specific inhibitor of HSPGs, and
protamine competes with LRP ligands for HSPG-binding sites (19).
Neither heparin (Figs. 2 and
6a) nor protamine (Fig. 2)
altered the level of Cy3 fluorescence within neurons after 30 min of
incubation, indicating that HSPGs are not required for anionic
liposome endocytosis by LRP.

View larger version (53K):
[in a new window]
Fig. 6.
Anionic liposome endocytosis by LRP is
independent of HSPGs and does not alter neuronal calcium contents.
a, neurons were treated with 100 µg/ml heparin prior to
incubation with AL-Cy3ONs. Scale bar = 5 µm.
b, fura-2 ratios in hippocampal neurons were not altered
during perfusion of anionic liposomes labeled with N-Rh-DOPE, but
increased in response to 100 µM N-methyl
D-aspartate. Data are from a representative field of 23 neurons from among 110 neurons imaged in five experiments.
c, an image taken at 24 min (asterisk in
b) indicated the uptake of N-Rh-DOPE within the same neurons
in the field. An image taken at comparable gains and wavelengths prior
to the anionic liposome perfusion was blank (not shown).
Analysis of endogenous protein binding to anionic liposomes
2-macroglobulin to cortical neurons caused a Ca2+ influx that was both spatially and
temporally discrete. Only ligands that bind LRP at multiple sites were
capable of eliciting this calcium response, indicating that receptor
dimerization was essential. To examine whether the endocytosis of
anionic liposomes via LRP causes Ca2+ influx into neurons,
we studied neuronal calcium influx during a continuous perfusion of
liposomes labeled with N-Rh-DOPE. Anionic liposomes did not evoke a
calcium response (Fig. 6b), although they were endocytosed
as evidenced by rhodamine fluorescence in the neurons after liposome
perfusion (Fig. 6c).

View larger version (61K):
[in a new window]
Fig. 7.
AL-Cy3ON endocytosis requires an intact
cytoskeleton and PI 3-kinase activity. Neurons pretreated with 5 µg/ml nocodazole (b), 100 µg/ml cytochalasin D
(c), or 100 nM wortmannin (d)
exhibited very low levels of Cy3 fluorescence compared with cells
treated with AL-Cy3ONs alone (a). Scale bars = 5 µm.

View larger version (65K):
[in a new window]
Fig. 8.
Cy3ONs delivered by anionic liposomes are
neither significantly recycled nor degraded, whereas liposomal lipids
are sorted into recycling compartments. Neurons were incubated
with Cy3ONs (red) and OG-Tf (green) for 1 h
(a), Cy3ONs (red) and Alexa 488-dextran
(green) for 3 h (b), N-Rh-DOPE
(red) and OG-Tf (green) for 1 h
(c), and N-Rh-DOPE (red) and Alexa 488-dextran
(green) for 3 h (d). Areas of colocalization
of the probes appear yellow. Scale bars = 5 µm.
Colocalization of Cy3ONs or rhodamine-labeled lipids (N-Rh-DOPE) with
transferrin or dextran in hippocampal neurons
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
| |
ACKNOWLEDGEMENTS |
|---|
We are grateful to Tanya Brustovetsky for culturing the hippocampal neurons, Sarah Turgasen and Eric Ericson for help with image processing and immunostaining, and Drs. Robert G. Thorne and Nikolai Brustovetsky for valuable discussions. We thank Dr. Guojun Bu (Washington University) and Dr. Dudley Strickland (American Red Cross) for the generous gifts of RAP and R2629, respectively.
| |
FOOTNOTES |
|---|
* This work was supported by the Pharmaceutical Research Fund (to Y.-E. R.), by a grant from the Huntington's Disease Society of America, and by National Institutes of Health Grant NS39414 (to J. M. D.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at
http://www.jbc.org) contains Figs. S1-S3
and additional references.
¶ To whom correspondence should be addressed. Tel.: 612-625-8447; Fax: 612-626-5009; E-mail: dubin001@tc.umn.edu.
Published, JBC Papers in Press, February 5, 2002, DOI 10.1074/jbc.M111764200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: Cy3ONs, Cy3-labeled oligonucleotides; LRP, low-density lipoprotein receptor-related protein; N-Rh-DOPE, lissamine rhodamine-labeled dioleoylphosphatidylethanolamine; AL-Cy3ONs, anionic liposome-encapsulated Cy3-labeled oligonucleotides; RAP, receptor-associated protein; OG-Tf, Oregon Green 488-transferrin; HSPGs, heparan sulfate proteoglycans; HIV, human immunodeficiency virus; PI, phosphatidylinositol; CBQCA, 3-(4-carboxybenzoyl)quinoline-2-carboxaldehyde.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Ryan, T. A.,
and Smith, S. J.
(1995)
Neuron
14,
983-989[CrossRef][Medline]
[Order article via Infotrieve] |
| 2. |
Man, Y. H.,
Lin, J. W., Ju, W. H.,
Ahmadian, G.,
Liu, L.,
Becker, L. E.,
Sheng, M.,
and Wang, Y. T.
(2000)
Neuron
25,
649-662[CrossRef][Medline]
[Order article via Infotrieve] |
| 3. |
Beattie, E. C.,
Howe, C. L.,
Wilde, A.,
Brodsky, F. M.,
and Mobley, W. C.
(2000)
J. Neurosci.
20,
7325-7333 |
| 4. |
Lakkaraju, A.,
Dubinsky, J. M.,
Low, W. C.,
and Rahman, Y.-E.
(2001)
J. Biol. Chem.
276,
32000-32007 |
| 5. |
Dubinsky, J. M.
(1993)
J. Neurosci.
13,
623-631[Abstract] |
| 6. |
Kounnas, M. Z.,
Moir, R. D.,
Rebeck, G. W.,
Bush, A. I.,
Argraves, W. S.,
Tanzi, R. E.,
Hyman, B. T.,
and Strickland, D. K.
(1995)
Cell
82,
331-340[CrossRef][Medline]
[Order article via Infotrieve] |
| 7. |
Bu, G.,
Maksymovitch, E. A.,
Nerbonne, J. M.,
and Schwartz, A. L.
(1994)
J. Biol. Chem.
269,
18521-18528 |
| 8. |
Prekeris, R.,
Foletti, D. L.,
and Scheller, R. H.
(1999)
J. Neurosci.
19,
10324-10337 |
| 9. |
Hemar, A.,
Olivo, J. C.,
Williamson, E.,
Saffrich, R.,
and Dotti, C. G.
(1997)
J. Neurosci.
17,
9026-9034 |
| 10. |
Brustovetsky, N.,
and Dubinsky, J. M.
(2000)
J. Neurosci.
20,
103-113 |
| 11. |
Johnson, J. E.,
Giorgione, J.,
and Newton, A. C.
(2000)
Biochemistry
39,
11360-11369[CrossRef][Medline]
[Order article via Infotrieve] |
| 12. |
Heuser, J. E.,
and Anderson, R. G.
(1989)
J. Cell Biol.
108,
389-400 |
| 13. |
Oka, J. A.,
Christensen, M. D.,
and Weigel, P. H.
(1989)
J. Biol. Chem.
264,
12016-12024 |
| 14. |
Brodin, L.,
Low, P.,
and Shupliakov, O.
(2000)
Curr. Opin. Neurobiol.
10,
312-320[CrossRef][Medline]
[Order article via Infotrieve] |
| 15. |
Lai, M. M.,
Luo, H. R.,
Burnett, P. E.,
Hong, J. J.,
and Snyder, S. H.
(2000)
J. Biol. Chem.
275,
34017-34020 |
| 16. |
Willnow, T. E.
(1999)
J. Mol. Med.
77,
306-315[CrossRef][Medline]
[Order article via Infotrieve] |
| 17. |
Williams, S. E.,
Ashcom, J. D.,
Argraves, W. S.,
and Strickland, D. K.
(1992)
J. Biol. Chem.
267,
9035-9040 |
| 18. |
Liu, Y.,
Jones, M.,
Hingtgen, C. M., Bu, G.,
Laribee, N.,
Tanzi, R. E.,
Moir, R. D.,
Nath, A.,
and He, J. J.
(2000)
Nat. Med.
6,
1380-1387[CrossRef][Medline]
[Order article via Infotrieve] |
| 19. |
Narita, M., Bu, G.,
Olins, G. M.,
Higuchi, D. A.,
Herz, J.,
Broze, G. J.,
and Schwartz, A. L.
(1995)
J. Biol. Chem.
270,
24800-24804 |
| 20. |
Bacskai, B. J.,
Xia, M. Q.,
Strickland, D. K.,
Rebeck, G. W.,
and Hyman, B. T.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
11551-11556 |
| 21. |
Zhuo, M.,
Holtzman, D. M., Li, Y.,
Osaka, H.,
DeMaro, J.,
Jacquin, M.,
and Bu, G.
(2000)
J. Neurosci.
20,
542-549 |
| 22. |
de Hoop, M. J.,
and Dotti, C. G.
(1993)
J. Cell Sci. Suppl.
17,
85-92[Medline]
[Order article via Infotrieve] |
| 23. |
Gaidarov, I.,
Santini, F.,
Warren, R. A.,
and Keen, J. H.
(1999)
Nat. Cell Biol.
1,
1-7[CrossRef][Medline]
[Order article via Infotrieve] |
| 24. |
Lamaze, C.,
Fujimoto, L. M.,
Yin, H. L.,
and Schmid, S. L.
(1997)
J. Biol. Chem.
272,
20332-20335 |
| 25. |
Maples, C. J.,
Ruiz, W. G.,
and Apodaca, G.
(1997)
J. Biol. Chem.
272,
6741-6751 |
| 26. |
Martys, J. L.,
Wjasow, C.,
Gangi, D. M.,
Kielian, M. C.,
McGraw, T. E.,
and Backer, J. M.
(1996)
J. Biol. Chem.
271,
10953-10962 |
| 27. |
Shpetner, H.,
Joly, M.,
Hartley, D.,
and Corvera, S.
(1996)
J. Cell Biol.
132,
595-605 |
| 28. |
Mukherjee, S.,
Soe, T. T.,
and Maxfield, F. R.
(1999)
J. Cell Biol.
144,
1271-1284 |
| 29. |
Willem, J.,
ter Beest, M.,
Scherphof, G.,
and Hoekstra, D.
(1990)
Eur. J. Cell Biol.
53,
173-184[Medline]
[Order article via Infotrieve] |
| 30. |
Fire, E.,
Brown, C. M.,
Roth, M. G.,
Henis, Y. I.,
and Petersen, N. O.
(1997)
J. Biol. Chem.
272,
29538-29545 |
| 31. |
Ko, K. W.,
Avramoglu, R. K.,
McLeod, R. S.,
Vukmirica, J.,
and Yao, Z.
(2001)
Biochemistry
40,
752-759[CrossRef][Medline]
[Order article via Infotrieve] |
| 32. |
Mayor, S.,
Sabharanjak, S.,
and Maxfield, F. R.
(1998)
EMBO J.
17,
4626-4638[CrossRef][Medline]
[Order article via Infotrieve] |
| 33. |
Junker, M.,
and Creutz, C. E.
(1993)
Biochemistry
32,
9968-9974[CrossRef][Medline]
[Order article via Infotrieve] |
| 34. |
Bu, G.,
Maksymovitch, E. A.,
Geuze, H.,
and Schwartz, A. L.
(1994)
J. Biol. Chem.
269,
29874-29882 |
| 35. |
Ko, K. W.,
McLeod, R. S.,
Avramoglu, R. K.,
Nimpf, J.,
FitzGerald, D. J.,
Vukmirica, J.,
and Yao, Z.
(1998)
J. Biol. Chem.
273,
27779-27785 |
| 36. |
Dolmer, K.,
Huang, W.,
and Gettins, P. G.
(2000)
J. Biol. Chem.
275,
3264-3269 |
| 37. |
Huang, W.,
Dolmer, K.,
and Gettins, P. G.
(1999)
J. Biol. Chem.
274,
14130-14136 |
| 38. |
Knauer, M. F.,
Crisp, R. J.,
Kridel, S. J.,
and Knauer, D. J.
(1999)
J. Biol. Chem.
274,
275-281 |
| 39. |
Moestrup, S. K.,
Gliemann, J.,
and Pallesen, G.
(1992)
Cell Tissue Res.
269,
375-382[CrossRef][Medline]
[Order article via Infotrieve] |
| 40. |
Cavalli, V.,
Vilbois, F.,
Corti, M.,
Marcote, M. J.,
Tamura, K.,
Karin, M.,
Arkinstall, S.,
and Gruenberg, J.
(2001)
Mol. Cell
7,
421-432[CrossRef][Medline]
[Order article via Infotrieve] |
| 41. |
Dietschy, J. M.,
and Turley, S. D.
(2001)
Curr. Opin. Lipidol.
12,
105-112[CrossRef][Medline]
[Order article via Infotrieve] |
| 42. |
Barres, B. A.,
and Smith, S. J.
(2001)
Science
294,
1296-1297 |
| 43. |
Narita, M., Bu, G.,
Holtzman, D. M.,
and Schwartz, A. L.
(1997)
J. Neurochem.
68,
587-595[Medline]
[Order article via Infotrieve] |
| 44. |
Mauch, D. H.,
Nagler, K.,
Schumacher, S.,
Goritz, C.,
Muller, E. C.,
Otto, A.,
and Pfrieger, F. W.
(2001)
Science
294,
1354-1357 |
| 45. |
Wells, K.,
Farooqui, A. A.,
Liss, L.,
and Horrocks, L. A.
(1995)
Neurochem. Res.
20,
1329-1333[CrossRef][Medline]
[Order article via Infotrieve] |
| 46. |
Geddes, J. W.,
Panchalingam, K.,
Keller, J. N.,
and Pettegrew, J. W.
(1997)
Neurobiol. Aging
18,
305-308[CrossRef][Medline]
[Order article via Infotrieve] |
| 47. |
Bu, G.,
Sun, Y.,
Schwartz, A. L.,
and Holtzman, D. M.
(1998)
J. Biol. Chem.
273,
13359-13365 |
| 48. |
Herz, J.
(2001)
Neuron
29,
571-581[CrossRef][Medline]
[Order article via Infotrieve] |
| 49. |
Gotthardt, M.,
Trommsdorff, M.,
Nevitt, M. F.,
Shelton, J.,
Richardson, J. A.,
Stockinger, W.,
Nimpf, J.,
and Herz, J.
(2000)
J. Biol. Chem.
275,
25616-25624 |
This article has been cited by other articles:
![]() |
Y. Kashiwakura, M. Watanabe, N. Kusumi, K. Sumiyoshi, Y. Nasu, H. Yamada, T. Sawamura, H. Kumon, K. Takei, and H. Daida Dynamin-2 Regulates Oxidized Low-Density Lipoprotein-Induced Apoptosis of Vascular Smooth Muscle Cell Circulation, November 23, 2004; 110(21): 3329 - 3334. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-y. Morita, M. Kawabe, A. Sakurai, K. Okuhira, A. Vertut-Doi, M. Nakano, and T. Handa Ceramide in Lipid Particles Enhances Heparan Sulfate Proteoglycan and Low Density Lipoprotein Receptor-related Protein-mediated Uptake by Macrophages J. Biol. Chem., June 4, 2004; 279(23): 24355 - 24361. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||